Frontier IP, a specialist in commercialising intellectual property is working in partnership to create a novel innovation hub ...

AstraZeneca has signed a research agreement worth more than US$5 billion with Chinese drugmaker CSPC Pharmaceutical Group, ...

Frontier IP announced on Friday that it has entered into a strategic partnership with property developer Abstract Mid-Tech to ...

“Straight out of the blocks,” he says, “Cambridge Wide Open Week has been a whirlwind of inspiring pitches, thought-provoking ...

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge ... could one day become a biotech hub to rival Boston and San Francisco in ...

AstraZeneca has revealed plans to set up a new strategic R&D hub in Cambridge, Massachusetts as it reported a massive increase in first-quarter revenues, driven by COVID-19 and oncology drugs and ...

Sotheby’s has finally revealed what its plans are for Breuer’s building. Today, the international auction house, alongside the Pritzker prize-winning architecture firm Herzog & de Meuron, unveiled ...

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

AstraZeneca announced a strategic research collaboration with CSPC Pharmaceuticals to advance AI-enabled drug discovery. This partnership aims to develop novel o ...

IonQ (IONQ) announced results of a research program between the company, AstraZeneca (AZN), Amazon Web Services (AMZN) and Nvidia (NVDA).